Results 191 to 200 of about 91,065 (316)

Context, mechanisms and outcomes of a social enterprise model of residential rehabilitation for problem substance use: A realist‐informed process evaluation

Addiction, EarlyView.
Abstract Background and aims This study evaluated a three‐year residential rehabilitation programme, which aimed to support recovery from problem substance use via peer support and social enterprise activities. The aims were to clarify programme mechanisms and identify contextual factors associated with variation in outcomes.
Martin Anderson, Lucy Pickering, Mark McCann   +2 more
wiley   +1 more source

Legislating novel psychoactive substances: lessons from 15 years of UK mortality data (2007-2022). [PDF]

Front Pharmacol
Rock KL, Treble R, Copeland CS.
europepmc   +1 more source

Legal Reponses to Novel Psychoactive Substances implemented by ten European Countries: an analysis from legal epidemiology

Emerging Trends in Drugs, Addictions, and Health, 2022
J. Neicun, A. Roman-Urrestarazu, K. Czabanowska   +2 more
semanticscholar   +1 more source

Brief report: Meth, tranq, gas station heroin & other drugs complicating addiction treatment

The American Journal on Addictions, EarlyView.
Abstract Background and Objectives Patients using fentanyl have worse treatment outcomes; however, little is known about other drugs that complicate treatment. Methods A national survey (n = 396) was conducted using a random sample of clinicians waivered to prescribe buprenorphine in the United States.
Erin L. Winstanley, Jane M. Liebschutz, Cristina Murray‐Krezan, Galen E. Switzer, Samantha Nash, Sarah Kawasaki   +5 more
wiley   +1 more source

Emergency department-based testing for xylazine and other novel psychoactive substances in Central Alabama: a feasibility study. [PDF]

Harm Reduct J
Bradford W, Dye D, Jensen R, Bratches R, Marshall S, Eaton E, Figgatt M, Taylor W, Walter LA, Goodman-Meza D, Kertesz S, Scott KS.   +11 more
europepmc   +1 more source

How deaths can help clinicians and policy-makers understand the risks of novel psychoactive substances. [PDF]

Br J Clin Pharmacol, 2020
Corkery JM, Schifano F, Martinotti G.
europepmc   +1 more source

Global Patterns of Fatalities With Toxicological Detection of Novel Psychoactive Substances: A Systematic Review and Meta-analysis. [PDF]

Cureus
Tyagi S, Singh JP, Manzoor A, Basra S, Sharma Y, Sharma P, Shubham, Kaur A, Kaur S.   +8 more
europepmc   +1 more source

“And then I got strangled”: Dangerous trends of sexual choking among young people

Acta Obstetricia et Gynecologica Scandinavica, EarlyView.
Sexual choking is increasingly normalized among young people yet is never medically safe; loss of consciousness can occur within seconds, making consent impossible to verify. Clinicians should routinely ask about choking, assess injuries, and counsel patients against breath‐control practices.
Katja Kero, Hannu Lauerma, Pia Wahlsten
wiley   +1 more source

Deadly confusion of novel psychoactive substances: fatal outcome of ADB-BUTINACA mislabeled as 3',4'-methylenedioxy-α-pyrrolidinohexiophenone. [PDF]

Forensic Toxicol
Zschiesche A, Theofel N, Braukmüller S, Ehrlich E, Jasyk M, Methling M, Tsokos M, Scholtis S, Huppertz LM, Auwärter V.   +9 more
europepmc   +1 more source

Individual novel psychoactive substances

, 2022
openaire   +1 more source